Brand family
Menveo
Meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine · GlaxoSmithKline Biologicals
United States
- Presentations
- 2
- Markets
- 1
Menveo is a brand of Meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine marketed by GlaxoSmithKline Biologicals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine
- Brand owner
- GlaxoSmithKline Biologicals
- Registered in
- United States
- Strengths and forms
- injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Menveo injectionIntramuscular | GlaxoSmithKline Biologicals | US FDA | Available on request |
| Menveo kit | GlaxoSmithKline Biologicals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Menveo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.